In vitro diagnostic industry (In Vitro Diagnostics, IVD), covering in vitro diagnostic reagents and diagnostic instruments supporting. As a biological / pharmaceutical industry, a young branch, is in rapid growth into, but it is the meaning of the whole industry has been far beyond its current size of the market. IVD industry in China has the typical small-scale industries, grow fast, the potential characteristics of a large space. People's livelihood and well-being of both the relationship between IVD industry, but also related to national strategic security, should have a number of strong national brands. Kehua is duty-bound to carry the banner of the revitalization of national IVD industry. Meanwhile, the development prospects of the Chinese IVD market is optimistic about the world, attracting almost all of the world's top multinational corporations into China.
    Compared with the multinational and domestic manufacturers of diagnostic reagents late start, there are small scale, fewer species, the development of imbalances. Although, through the efforts of recent years, some of the major domestic manufacturers of diagnostic reagents conventional production technology has reached the international level over the same period, but overall, still long way to go.

    China's diagnostic reagent market is brought together hundreds of brands at home and abroad, has been in biochemical, immunological, nucleic acids, and other areas of the instruments and reagents fierce competition, and jointly promote the development of our IVD industry, and growth.

    IVD products market segments, the major domestic competition as follows:

Market segments

 Competition

 Superior domestic manufacturers

 Advantages of foreign manufacturers 
 
Biochemical diagnosis

 Higher cost domestic products; foreign products through the high-performance instruments and reagents occupy the high-end market.

 Kehua, Leadman, etc.   

 Roche, Beckman 
 
Immunodiagnosis

 Conventional enzyme immunoassay for the absolute leading domestic companies; Zeyi emerging technologies such as chemiluminescence dominant foreign products.

 Kehua, Manhattan, etc.

 Abbott, Roche 
 
Blood glucose testing

 Monopoly of foreign products.  

 Johnson & Johnson, Roche 
 
Clinical DNA

 Domestic conventional products have reached international standards over the same period, representing an absolute advantage.

 Tat, Kehua, horse-based  

  Nucleic acid screening of blood

 To Roche and Branch, are represented by the formation of foreign and domestic companies keen competition.

 Branch,

 Roche, Novartis

 
IVD Instruments

 Monopoly of multinational companies manufacturing high-end equipment, and the following end products in the domestic companies with strong competitive advantages

 Mindray, China Division

 Hitachi, Toshiba, Olympus, West U.S. recreational Vacuum Blood

 Domestic manufacturers of vacuum blood collection system, occupied by gradually expanding the domestic market share.

 Yang Pu, Branch, etc.

 BD, GREINER, etc.  

    Can be seen from the above chart, in the Chinese IVD market sectors, multinational companies and domestic enterprises have launched a contest, Roche and other multinational companies still represent the IVD industry in the world leading level, but Kehua headed by leading enterprises in the domestic part of the IVD , based on clear development strategy, the development of independent research and development model, enriched by its own product line of business forum and raised high the banner of national rejuvenation IVD industry.

    Strategy is the root

    Kehua through years of meticulous work, laid the status of leading enterprises in domestic IVD, and eyes on a broader international market. Strategy is the root of enterprise development, scientific development of China's own bio on a clear strategy: to make China the largest and strongest international diagnostic products company.

    R & D is dry

    Branch, in terms of R & D innovation means the development of enterprises, but also determines the survival of enterprises. Relying on innovation center of biotechnology and post-doctoral workstations, Branch, created a diagnostic reagents and automated instruments are two R & D platform, and comprehensively promote the reagents and equipment "series, integration" development goals, now has 121 products, number, 56 key products through the EU CE certification, triple nucleic acid reagents, "excellent" biochemical analyzer, workstations and other high-end large-scale nucleic acid products lead the trend. With strong technical innovation strength, Branch, featuring lead the "National Eleventh Five-Year Science and Technology Project", the "City of Shanghai through science and education project" and more than ten national and provincial scientific and technological issues. Rely on strong innovation engine, Branch, focused on achieving efficiency and value of clinical diagnosis of the double upgrade. It is this core of research and development as the driving force of the model to ensure the Branch, the most comprehensive set of product line structure.

    Product line is a leaf

    The company business covers the IVD industry, diagnostic reagents, medical equipment, sample collection systems. The future, Branch, will also open up new business segments. Closely around the company's extension and expansion for the core business diagnostics to diagnostic reagents and related products upstream and downstream areas of development, not only to strengthen the core business competitiveness, but also effectively avoid the diagnosis of primary industry to develop other non-risks. 

    Even more commendable is that different from most of the Branch, there are two main characteristics of domestic enterprises:

    1. Product line full, rich, and in the biochemical, immunological, nucleic acid clinical, nucleic acid blood screening and other major market segments remain the leading market position relative to the achievements of the size of the domestic market share leader in IVD.

    2. Branch, "excellent" series of biochemical analyzer instrument manufacturing business represented more than 50% at an average annual rate of growth, rapid near Branch, reagent market position. Balanced development of reagents and instruments, the most close to leading the company's development.

    The above two points, fully embodies the Branch, the years leading national brand development and catch up with international leaders care and thought and foresight. Reagents, equipment supporting, integrated development for the clinical laboratory to provide a relatively comprehensive solution, but also international IVD giant Roche, and most other Chinese companies significantly compared to the overall advantage. In the revitalization of this protracted war of national IVD industry, the Division of Chinese are targeted to the layout of your future, hold the pace to catch up.

    As the largest professional IVD market, listed companies, Branch, has a great management team, the transparent operation of the system and regulate the market conduct. Branch, has a most busy and diagnostic supplies the most extensive marketing and service network, every day for more than 600 dealer customers and 6,000 end-users with high quality brands and services. As the World Health Organization, UNICEF, and the Clinton Foundation's global suppliers, Branch, reagents and instruments has been achieved in more than 30 countries overseas sales and become the vanguard of IVD products to the world.

    Section China's leading position in domestic industry, not just the scale of the advantages of simple sales, but also in the industrial layout, the layout of product lines and marketing network layout, integrated management capabilities, R & D and innovation strength, and many other leading balanced, so we see their catch up with advanced foreign companies continue to revitalize the national IVD industry potential.

    Trickle, Branch, all the way up to today, as industry leaders, the achievements are brought together all the glory of countless customers and employees the support and efforts. Branch, to thank those who have been supporting Branch, brand, success Branch, today's customers and employees. Branch, expect fair competition in the market, continue to provide customers with the best price-return services, to achieve the revitalization of the glorious mission of national IVD brand!